← Leaderboards
Catherine F Siengsukon
University Of Kansas Medical Center
$3,672,490
Attributed
$3,672,490
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $764K · FY2019–23$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,672,490 · 1
By mechanism
R01$3,672,490 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Kansas Medical Center
Same institution · by research overlap
- Russell H Swerdlow$17,139,092
- Lisa Sanderson Cox$9,189,363
- Nicole L Nollen$14,451,588
- Megha Ramaswamy$8,430,978
- Dev Karan$2,651,533
Others in their field
Other Emerging Leaders on “Abeta Deposition”
- Niccolo Terrando · Duke University$6,674,487
- Yi Li · New York University School Of Medicine$5,557,834
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,348,514
- John R Lukens · University Of Virginia$5,100,546
- Victor Luis Villemagne · University Of Pittsburgh At Pittsburgh$5,047,073
- Gloria Chia-Yi Chiang · Weill Medical Coll Of Cornell Univ$4,572,626
Research focus
Abeta DepositionElderlyAge-Associated Memory ImpairmentAlzheimer&AposAbeta AccumulationActive ControlAmyloid Beta-ProteinAnteriorBrainCharacteristicsAlzheimer Disease PreventionClinical TrialsCognitiveCognitive FunctionCognitive TestingCognitive TherapyComorbidityComparative EfficacyCritical PeriodDiagnosisDietEffective InterventionChronic InsomniaEpisodic Memory
Grant awards (5)
Primary Prevention of Alzheimer's disease: Examining the effects of cognitive behavioral therapy on cognitive function and amyloid-beta in older adults with symptoms of insomnia$699,698
R01 · FY2023 · AG · contact PI
Primary Prevention of Alzheimer's disease: Examining the effects of cognitive behavioral therapy on cognitive function and amyloid-beta in older adults with symptoms of insomnia$721,234
R01 · FY2022 · AG · contact PI
Primary Prevention of Alzheimer's disease: Examining the effects of cognitive behavioral therapy on cognitive function and amyloid-beta in older adults with symptoms of insomnia$736,351
R01 · FY2021 · AG · contact PI
Primary Prevention of Alzheimer's disease: Examining the effects of cognitive behavioral therapy on cognitive function and amyloid-beta in older adults with symptoms of insomnia$751,228
R01 · FY2020 · AG · contact PI
Primary Prevention of Alzheimer's disease: Examining the effects of cognitive behavioral therapy on cognitive function and amyloid-beta in older adults with symptoms of insomnia$763,979
R01 · FY2019 · AG · contact PI